A RANDOMIZED OPEN LABEL COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF TRIVRIT TAILA PICHUU AND LAJJALU TAILA PICHUU IN THE MANAGEMENT OF PRASRAMSINI YONIVYAPAD W.S.R 1ST AND 2ND DEGREE UTERINE PROLAPSE
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- IMPROVEMENT IN QUANTITATIVE GRADING OF POP FOR UTERINE PROLAPSE
研究概览
简要总结
PRASRAMSINI YONIVYAPAD IS ONE OF PITTAJ YONIVYAPAD AS DESCRIBED BY ACHARYA SUSHRUT WHICH IS CLINICALLY CORRELATED TO FIRST AND SECOND DEGREE UTERINE PROLAPSE
IT IS THE HERNIATION OF UTERUS INTO OR BEYOND THE VAGINA DUE TO FAILURE OF LIGAMENTOUS AND FASCIAL SUPPPORT WHO ESTIMATE THE GLOBAL PREVELANCE RATE 2 TO 20 PERCENT OF UTERINE PROLAPSE
AS PRASRAMSINI YONIVYAPAD IS A VATA ASSOCIATED PITTAJ YONIVYAPAD SO THIS STUDY AIMS TO EVALUATE THE EFFICACY OF TRIVRIT TAILA AND LAJJALU TAILA PICHUU AS BOTH DRUGS ARE PITTAHAR IN NATURE AND TAILA IS ONE OF BEST SNEHA FOR VATA IMBALANCE AND STHANIK CHIKITSA GIVES STRENGTH TO THE TISSUE REMOVING LAXITY WHICH IS BASIC DEFECT IN THIS YONIVYAPAD SO IN FORM OF PICHUU COORECTING IMBALANCE OF DOSHA AND IMPROVING QUALITY OF LIFE WITH COST EFFECTIVE AND CONSERVATIVE METHOD
25 PATIENT ASSIGNED IN EACH INTERVENTION ARM AND ASSESSMENT WILL NE DONE ON BASIS OF QUANTITATIVE GRADING OF POP AND CONCLUSION WILL BE DRAWN FROM STATISTICAL METHOD
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 30.00 Year(s) 至 55.00 Year(s)（—）
- 性别
- Female
入选标准
- •PATIENTS HAVING AGE GROUP FROM 30 TO 55 YEARS PATIENTS HAVING FIRST AND SECOND DEGREE UTERINE PROLAPSE PATIENTS HAVING FIRST DEGREE UTERINE PROLAPSE WITH CYSTOCELE OR RECTOCELE PATIENTS HAVING CLINICAL SIGN AND SYMPTOMS OF UTERINE PROLAPSE PATIENTS WILLING TO PARTICIPATE IN TRIAL.
排除标准
- •PATIENTS BELOW AGE OF 30 YEARS AND ABOVE AGE OF 55 YEARS PATIENTS HAVING THIRD DEGREE UTERINE PROLAPSE PREGNANCY CASES PATIENT HAVING CERVIX AND UTERINE MALIGNANCY PATIENTS HAVING PROCIDENTIA WITH DECUBITUS ULCER OR VAULT PROLAPSE PATIENTS WITH CONGENITAL PROLAPSE OR ELONGATION OF CERVIX PATIENTS HAVING RECTAL PROLAPSE OR PELVIC INFLAMMATORY DISEASE PATIENT PRESENTED WITH KNOWN CASE OF SEXUALLY TRANSMITTED DISEASE FIBROID POLYP.
结局指标
主要结局
IMPROVEMENT IN QUANTITATIVE GRADING OF POP FOR UTERINE PROLAPSE
时间窗: FOLLOW UP WILL BE DONE ON 30TH 60TH 90TH DAY
次要结局
- IMPROVEMENT IN SIGN AND SYMPTOMS AND CHANGES IN ASSOCIATED CLINICAL FEATURES RELATED TO UTERINE PROLAPSE(FOLLOW UP WILL BE DONE ON 8TH 14TH 30TH 38TH 44TH 60TH 68TH 74TH 90TH DAY)
研究者
DR NISHU NARWAL
INSTITUTE FOR AYURVED STUDIES AND RESEARCH